Asia Pacific Gastrointestinal Drugs Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Gastrointestinal Drugs Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Gastrointestinal Drugs Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Gastrointestinal Drugs Market Regional Analysis

6.2 Asia Pacific Gastrointestinal Drugs Market Revenue 2021-2031 (US$ Million)

6.3 Asia Pacific Gastrointestinal Drugs Market Forecast Analysis

7. Asia Pacific Gastrointestinal Drugs Market Analysis – by Drug Class

7.1 Biologics

7.1.1 Overview
7.1.2 Biologics: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Antidiarrheal and Laxatives

7.2.1 Overview
7.2.2 Antidiarrheal and Laxatives: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Acid Neutralizers

7.3.1 Overview
7.3.2 Acid Neutralizers: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Anti-inflammatory Drugs

7.4.1 Overview
7.4.2 Anti-inflammatory Drugs: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Antiemetic and Antinauseants

7.5.1 Overview
7.5.2 Antiemetic and Antinauseants: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Others

7.6.1 Overview
7.6.2 Others: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Gastrointestinal Drugs Market Analysis – by Application

8.1 Irritable Bowel Syndrome

8.1.1 Overview
8.1.2 Irritable Bowel Syndrome: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Inflammatory Ulcerative Colitis

8.2.1 Overview
8.2.2 Inflammatory Ulcerative Colitis: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Crohn\'s Disease

8.3.1 Overview
8.3.2 Crohn\'s Disease: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Gastroenteritis

8.4.1 Overview
8.4.2 Gastroenteritis: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Celiac Disease

8.5.1 Overview
8.5.2 Celiac Disease: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Others

8.6.1 Overview
8.6.2 Others: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Gastrointestinal Drugs Market Analysis – by Route Of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Parenteral

9.2.1 Overview
9.2.2 Parenteral: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Gastrointestinal Drugs Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Retail Pharmacies

10.2.1 Overview
10.2.2 Retail Pharmacies: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Online Pharmacies

10.3.1 Overview
10.3.2 Online Pharmacies: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Asia Pacific Gastrointestinal Drugs Market – Asia Pacific Analysis

11.1 Overview

11.2 Asia Pacific

11.2.1 Asia Pacific Gastrointestinal Drugs Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country
11.2.1.1 India: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 India: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.1.2 India: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.1.3 India: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.1.4 India: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.2 China: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 China: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.2.2 China: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.2.3 China: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.2.4 China: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.3 Japan: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.3.2 Japan: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.3.3 Japan: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.3.4 Japan: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.4 South Korea: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 South Korea: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.4.2 South Korea: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.4.3 South Korea: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.4.4 South Korea: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.5 Australia: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Australia: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.5.2 Australia: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.5.3 Australia: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.5.4 Australia: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.2.1.6 Rest of Asia Pacific: Asia Pacific Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Rest of Asia Pacific: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Drug Class
11.2.1.6.2 Rest of Asia Pacific: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Application
11.2.1.6.3 Rest of Asia Pacific: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Route Of Administration
11.2.1.6.4 Rest of Asia Pacific: Asia Pacific Gastrointestinal Drugs Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Sanofi SA

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 GSK Plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Johnson & Johnson

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bausch Health Companies Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 AstraZeneca Plc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Takeda Pharmaceutical Co Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 AbbVie Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Bayer AG

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Celltrion Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Pfizer Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Gastrointestinal Drugs Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis